DocMorris integrates Caire Health AI’s smartphone-based vital signs monitoring
DocMorris has integrated Caire Health AI’s AI-powered Vital Signs Check into its health platform, enabling users to estimate blood pressure, pulse rate, and respiratory rate through a standard smartphone camera in approximately 30 seconds. The technology uses remote photoplethysmography (rPPG) and AI to analyse subtle changes in facial skin-light reflection without requiring additional hardware or physical contact. The integration expands DocMorris’s digital health ecosystem into everyday vital signs monitoring, with video recordings processed in real time and not stored. The feature is intended for personal health guidance rather than medical diagnosis.
Neurotronics receives FDA clearance for AI-powered sleep analysis module
Neurotronics, a Nihon Kohden company, has received FDA 510(k) clearance for its Sleep Analysis Module (SAM), an AI/ML-based software medical device designed to estimate total sleep time using photoplethysmography (PPG) signals collected by pulse oximeters. The technology provides clinicians with additional information for interpreting home sleep apnea tests without requiring additional sensors or changes to existing patient setups. SAM will initially be integrated into Neurotronics’ Polysmith sleep diagnostic software for studies recorded through its NomadAir home sleep apnea testing solution, marking the company’s first FDA-cleared AI/ML-based sleep analysis algorithm.
Hippocratic AI unveils Polaris 6 Ultra for advanced AI-powered patient care
Hippocratic AI has introduced Polaris 6 Ultra, an upgraded healthcare language model designed to deliver faster, more natural, and empathetic AI-powered patient interactions. Built on more than 323 million patient conversations, the platform introduces six upgrades spanning real-time clinical reasoning, emotional awareness, voice generation, speech recognition, and safety monitoring, with a reported 1.3× improvement in processing speed over Polaris 5. Its architecture combines a 671-billion-parameter primary model with 30 specialist supervisors and 142 production monitors, while the company reports a 0.00% minor-harm rate in clinician output testing. Available in four versions for clinical, sub-clinical, and administrative workflows, Polaris 6 Ultra aims to expand AI-supported patient engagement and healthcare operations.
